Itacitinib for Low Risk GVHD

Clinical trial NCT03846479 · COMPLETED

Trial details

NCT number: NCT03846479
Sponsor: John Levine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Low Risk Acute Graft-versus-host Disease Graft-versus-host-disease GVHD

Start date: 2019-03-25
Primary completion: 2021-05-07
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.